OA10355A - 1,5 Benzodiazepine derivatives having cck antagonistic or agonistic activity - Google Patents

1,5 Benzodiazepine derivatives having cck antagonistic or agonistic activity Download PDF

Info

Publication number: OA10355A
Authority: OA; OAPI
Prior art keywords: phenyl; formula; group; 4alkyl; compound
Prior art date: 1993-04-15

Application number

OA60722A

Other languages

English (en)

Inventor

Elizabeth Ellen Sugg

Christopher Joseph Aquino

Jerzy Ryszard Szewczyk

Harry Finch

Robin Arthur Ellis Carr

Original Assignee

Glaxo Wellcome Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-15

Filing date

1995-10-12

Publication date

2001-10-19

1995-10-12 Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc

2001-10-19 Publication of OA10355A publication Critical patent/OA10355A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Crystallography & Structural Chemistry (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Hydrogenated Pyridines (AREA)

OA60722A 1993-04-15 1995-10-12 1,5 Benzodiazepine derivatives having cck antagonistic or agonistic activity OA10355A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939307833A GB9307833D0 (en)	1993-04-15	1993-04-15	Modulators of cholecystokinin and gastrin

Publications (1)

Publication Number	Publication Date
OA10355A true OA10355A (en)	2001-10-19

Family

ID=10733915

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA60722A OA10355A (en)	1993-04-15	1995-10-12	1,5 Benzodiazepine derivatives having cck antagonistic or agonistic activity

Country Status (33)

Country	Link
US (2)	US5646140A (is)
EP (1)	EP0694039B1 (is)
JP (1)	JP3406317B2 (is)
KR (1)	KR100364948B1 (is)
CN (1)	CN1058487C (is)
AP (2)	AP512A (is)
AT (1)	ATE198894T1 (is)
AU (1)	AU681139B2 (is)
CA (1)	CA2158973C (is)
CZ (1)	CZ286695B6 (is)
DE (1)	DE69426624T2 (is)
DK (1)	DK0694039T3 (is)
EC (1)	ECSP941066A (is)
ES (1)	ES2154674T3 (is)
FI (1)	FI954853L (is)
GB (1)	GB9307833D0 (is)
GR (1)	GR3035641T3 (is)
HU (1)	HU223467B1 (is)
IL (2)	IL109315A0 (is)
IS (2)	IS4148A (is)
MY (2)	MY112237A (is)
NO (1)	NO311133B1 (is)
NZ (1)	NZ265272A (is)
OA (1)	OA10355A (is)
PE (2)	PE50594A1 (is)
PH (1)	PH30897A (is)
PL (1)	PL178790B1 (is)
PT (1)	PT694039E (is)
RU (1)	RU2135486C1 (is)
SK (1)	SK281211B6 (is)
TW (1)	TW487703B (is)
WO (1)	WO1994024149A1 (is)
ZA (2)	ZA942571B (is)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995018110A1 (en) *	1993-12-28	1995-07-06	Shionogi & Co., Ltd.	Novel benzodiazepine derivative
US5739129A (en) *	1994-04-14	1998-04-14	Glaxo Wellcome Inc.	CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
KR970702274A (ko) *	1994-04-14	1997-05-13	앨런 헤스케쓰	콜레시스토키닌 또는 가스트린을 조절하는 5-헤테로시클릭-1, 5-벤조디아제핀(CCK or Gastrin Modulating 5-Heterocyclic-1,5-Benzodiazepines)
PE27497A1 (es) *	1994-04-15	1997-08-07	Glaxo Inc	Derivados de 1,5 benzodiazepina
US5795887A (en) *	1994-04-15	1998-08-18	Glaxo Wellcome Inc.	Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
GB9420747D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	1,5 benzodiazepine derivatives
US5780464A (en) *	1994-10-14	1998-07-14	Glaxo Wellcome Inc.	Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
GB9420763D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	Acetamide derivatives
GB9420748D0 (en) *	1994-10-14	1994-11-30	Glaxo Inc	1,5 benzodiazepine derivatives
US5910495A (en) *	1994-10-14	1999-06-08	Glaxo Wellcome Inc.	Use of 1,5-benzo b!1,4-diazepines to control gastric emptying
JP4442930B2 (ja)	1995-12-11	2010-03-31	タフツメディカルセンターインコーポレイテッド	ペプチドホルモンレセプターリガンドに関するアッセイ法およびその使用
US5750353A (en) *	1995-12-11	1998-05-12	New England Medical Center Hospitals, Inc.	Assay for non-peptide agonists to peptide hormone receptors
CA2274669C (en) *	1996-12-10	2006-11-14	Zeria Pharmaceutical Co., Ltd.	1,5-benzodiazepine derivatives
AP2003002729A0 (en)	1997-04-15	2003-06-30	Csir	Pharmaceutical compositions having appetite suppressant activity
AR022044A1 (es) *	1999-05-06	2002-09-04	Glaxo Group Ltd	Derivados de 1,5-benzodiazepina
GB2355657B (en)	1999-10-27	2004-07-28	Phytopharm Plc	Inhibitors Of Gastric Acid Secretion
GB2363985B (en)	2000-06-30	2004-09-29	Phytopharm Plc	Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US6768024B1 (en)	2000-08-04	2004-07-27	Lion Bioscience Ag	Triamine derivative melanocortin receptor ligands and methods of using same
US20020180095A1 (en) *	2001-05-29	2002-12-05	Berard Steven O.	Thermally conductive carbon fiber extrusion compounder and method of using same
US7074805B2 (en) *	2002-02-20	2006-07-11	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
CA2476936A1 (en) *	2002-02-20	2003-08-28	Chih-Hung Lee	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
US6933311B2 (en) *	2003-02-11	2005-08-23	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7015233B2 (en) *	2003-06-12	2006-03-21	Abbott Laboratories	Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
RU2261246C1 (ru) *	2004-04-15	2005-09-27	Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия")	Замещенные 7-сульфонил бензо[b][1,4]диазепины (варианты), способы их получения (варианты), фокусированная библиотека и фармацевтическая композиция
AP2006003768A0 (en) *	2004-05-25	2006-10-31	Pfizer Prod Inc	TetraazabenzoÄeÜazulene derivatives and analogs tehereof
CN1333077C (zh) *	2005-04-15	2007-08-22	华南农业大学	缩胆囊素活性片段的串联表达及其应用
RU2303597C1 (ru) *	2006-05-12	2007-07-27	Иващенко Андрей Александрович	Фармацевтическая композиция, способы ее получения и применения
CN101541758A (zh) *	2006-08-25	2009-09-23	艾博特公司	抑制trpv1的吲唑衍生物及其用途
WO2008079683A2 (en)	2006-12-20	2008-07-03	Abbott Laboratories	N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
CN102036969A (zh) *	2008-03-20	2011-04-27	雅培制药有限公司	制造作为trpv1拮抗剂的中枢神经系统药剂的方法
CN103102285B (zh) *	2013-01-30	2015-07-29	淮阴师范学院	对氨基苯乙腈的制备方法
WO2015074064A2 (en)	2013-11-18	2015-05-21	Bair Kenneth W	Tetrahydroquinoline compositions as bet bromodomain inhibitors
US9422281B2 (en)	2013-11-18	2016-08-23	Forma Therapeutics, Inc.	Benzopiperazine compositions as BET bromodomain inhibitors
AU2016297024B2 (en)	2015-07-22	2021-03-04	Enanta Pharmaceuticals, Inc.	Benzodiazepine derivatives as RSV inhibitors
IL287136B2 (en)	2016-02-05	2023-09-01	Denali Therapeutics Inc	Receptor inhibitors - interacting with protein kinase 1
HUE058802T2 (hu)	2016-12-09	2022-09-28	Denali Therapeutics Inc	RIPK1 inhibitorokként alkalmas vegyületek
AU2018221820B2 (en)	2017-02-16	2023-11-02	Enanta Pharmaceuticals, Inc.	Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) *	2017-06-07	2018-12-13	Enanta Pharmaceuticals, Inc.	Aryldiazepine derivatives as rsv inhibitors
WO2019006295A1 (en)	2017-06-30	2019-01-03	Enanta Pharmaceuticals, Inc.	HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019006291A1 (en)	2017-06-30	2019-01-03	Enanta Pharmaceuticals, Inc.	HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019067864A1 (en)	2017-09-29	2019-04-04	Enanta Pharmaceuticals, Inc.	PHARMACEUTICAL AGENTS IN COMBINATION AS INHIBITORS OF RSV
WO2019094920A1 (en)	2017-11-13	2019-05-16	Enanta Pharmaceuticals, Inc.	Azepin-2-one derivatives as rsv inhibitors
US10975094B2 (en)	2018-04-11	2021-04-13	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as RSV inhibitors
JP7558189B2 (ja)	2019-03-18	2024-09-30	エナンタファーマシューティカルズインコーポレイテッド	Ｒｓｖ阻害剤としてのベンゾジアゼピン誘導体
US11179400B2 (en)	2019-04-09	2021-11-23	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as RSV inhibitors
US11505558B1 (en)	2019-10-04	2022-11-22	Enanta Pharmaceuticals, Inc.	Antiviral heterocyclic compounds
UY39032A (es)	2020-01-24	2021-07-30	Enanta Pharm Inc	Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en)	2020-07-07	2022-12-27	Enanta Pharmaceuticals, Inc.	Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
US11945824B2 (en)	2020-10-19	2024-04-02	Enanta Pharmaceuticals, Inc.	Heterocyclic compounds as anti-viral agents
US11999750B2 (en)	2022-01-12	2024-06-04	Denali Therapeutics Inc.	Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
AR129003A1 (es)	2022-04-07	2024-07-03	Enanta Pharm Inc	Compuestos heterocíclicos antivirales
WO2023211997A1 (en)	2022-04-27	2023-11-02	Enanta Pharmaceuticals, Inc.	Antiviral compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4517195A (en) *	1984-07-02	1985-05-14	Hoechst-Roussel Pharmaceuticals Inc.	Pyrrolo[1,2-b][1,2,5]triazepines and pharmaceutical compositions thereof
FR2641280B1 (fr) *	1988-12-29	1994-01-21	Roussel Uclaf	Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
SU1362732A1 (ru) *	1986-04-16	1987-12-30	Ленинградский Технологический Институт Им.Ленсовета	Способ получени 2-диалкиламино-4-метил-3н-1,5-бензодиазепинов
CH673947A5 (is) *	1986-09-23	1990-04-30	Sandoz Ag
FR2659653B1 (fr) *	1990-03-13	1992-05-22	Rhone Poulenc Sante	Derives de l'uree, leur preparation et les medicaments les contenant.
US5206234A (en) *	1990-10-22	1993-04-27	Merck & Co., Inc.	Benzolactam analogs as antagonists of cck
JP2904941B2 (ja) *	1991-01-28	1999-06-14	出光興産株式会社	スチレン系重合体の精製方法
GB9201180D0 (en) *	1992-01-21	1992-03-11	Glaxo Group Ltd	Chemical compounds
KR970702274A (ko) *	1994-04-14	1997-05-13	앨런 헤스케쓰	콜레시스토키닌 또는 가스트린을 조절하는 5-헤테로시클릭-1, 5-벤조디아제핀(CCK or Gastrin Modulating 5-Heterocyclic-1,5-Benzodiazepines)

1993
- 1993-04-15 GB GB939307833A patent/GB9307833D0/en active Pending
1994
- 1994-01-04 US US08/525,659 patent/US5646140A/en not_active Expired - Lifetime
- 1994-04-11 IS IS4148A patent/IS4148A/is unknown
- 1994-04-11 IS IS4147A patent/IS4147A/is unknown
- 1994-04-12 MY MYPI94000880A patent/MY112237A/en unknown
- 1994-04-12 EC EC1994001066A patent/ECSP941066A/es unknown
- 1994-04-12 MY MYPI94000884A patent/MY131569A/en unknown
- 1994-04-13 IL IL10931594A patent/IL109315A0/xx unknown
- 1994-04-13 IL IL10931694A patent/IL109316A/en not_active IP Right Cessation
- 1994-04-13 PE PE1994240028A patent/PE50594A1/es not_active Application Discontinuation
- 1994-04-13 PE PE1994240027A patent/PE50994A1/es not_active Application Discontinuation
- 1994-04-13 AP APAP/P/1994/000635A patent/AP512A/en active
- 1994-04-13 US US08/522,363 patent/US5585376A/en not_active Expired - Fee Related
- 1994-04-13 AP APAP/P/1994/000634A patent/AP462A/en active
- 1994-04-14 PT PT94913580T patent/PT694039E/pt unknown
- 1994-04-14 CA CA002158973A patent/CA2158973C/en not_active Expired - Fee Related
- 1994-04-14 AT AT94913580T patent/ATE198894T1/de not_active IP Right Cessation
- 1994-04-14 SK SK1253-95A patent/SK281211B6/sk unknown
- 1994-04-14 FI FI954853A patent/FI954853L/fi unknown
- 1994-04-14 NZ NZ265272A patent/NZ265272A/en not_active IP Right Cessation
- 1994-04-14 AU AU65676/94A patent/AU681139B2/en not_active Ceased
- 1994-04-14 PH PH48093A patent/PH30897A/en unknown
- 1994-04-14 RU RU95117974A patent/RU2135486C1/ru not_active IP Right Cessation
- 1994-04-14 CZ CZ19952675A patent/CZ286695B6/cs not_active IP Right Cessation
- 1994-04-14 PL PL94311084A patent/PL178790B1/pl unknown
- 1994-04-14 ZA ZA942571A patent/ZA942571B/xx unknown
- 1994-04-14 KR KR1019950704491A patent/KR100364948B1/ko not_active Expired - Fee Related
- 1994-04-14 CN CN94191773A patent/CN1058487C/zh not_active Expired - Fee Related
- 1994-04-14 HU HU9502978A patent/HU223467B1/hu not_active IP Right Cessation
- 1994-04-14 WO PCT/EP1994/001131 patent/WO1994024149A1/en not_active Ceased
- 1994-04-14 DK DK94913580T patent/DK0694039T3/da active
- 1994-04-14 EP EP94913580A patent/EP0694039B1/en not_active Expired - Lifetime
- 1994-04-14 DE DE69426624T patent/DE69426624T2/de not_active Expired - Lifetime
- 1994-04-14 JP JP52273494A patent/JP3406317B2/ja not_active Expired - Fee Related
- 1994-04-14 ZA ZA942570A patent/ZA942570B/xx unknown
- 1994-04-14 ES ES94913580T patent/ES2154674T3/es not_active Expired - Lifetime
- 1994-05-26 TW TW083104772A patent/TW487703B/zh not_active IP Right Cessation
1995
- 1995-10-12 OA OA60722A patent/OA10355A/en unknown
- 1995-10-13 NO NO19954090A patent/NO311133B1/no unknown
2001
- 2001-03-27 GR GR20010400488T patent/GR3035641T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
MY112237A (en)	2001-05-31
WO1994024149A1 (en)	1994-10-27
PL178790B1 (pl)	2000-06-30
FI954853A0 (fi)	1995-10-12
US5585376A (en)	1996-12-17
PT694039E (pt)	2001-06-29
ZA942570B (en)	1994-11-11
CZ267595A3 (en)	1996-04-17
DE69426624D1 (de)	2001-03-01
RU2135486C1 (ru)	1999-08-27
EP0694039B1 (en)	2001-01-24
AP9400634A0 (en)	1994-04-30
CA2158973C (en)	2006-06-06
IL109315A0 (en)	1994-07-31
PE50594A1 (es)	1995-01-06
IL109316A (en)	1999-03-12
ZA942571B (en)	1994-11-11
US5646140A (en)	1997-07-08
PE50994A1 (es)	1995-01-06
TW487703B (en)	2002-05-21
JP3406317B2 (ja)	2003-05-12
IS4147A (is)	1994-10-16
DK0694039T3 (da)	2001-05-21
AP462A (en)	1996-02-19
AP512A (en)	1996-07-29
NO311133B1 (no)	2001-10-15
ECSP941066A (es)	1994-11-16
NO954090D0 (no)	1995-10-13
FI954853A7 (fi)	1995-10-12
HU9502978D0 (en)	1995-12-28
IS4148A (is)	1994-10-16
JPH08508744A (ja)	1996-09-17
AP9400635A0 (en)	1994-04-30
CA2158973A1 (en)	1994-10-27
GR3035641T3 (en)	2001-06-29
SK125395A3 (en)	1996-06-05
HK1003943A1 (en)	1998-11-13
IL109316A0 (en)	1994-07-31
PH30897A (en)	1997-12-23
ATE198894T1 (de)	2001-02-15
GB9307833D0 (en)	1993-06-02
HU223467B1 (hu)	2004-07-28
EP0694039A1 (en)	1996-01-31
FI954853L (fi)	1995-10-12
HUT74102A (en)	1996-11-28
CN1120843A (zh)	1996-04-17
DE69426624T2 (de)	2001-06-21
PL311084A1 (en)	1996-02-05
CZ286695B6 (en)	2000-06-14
AU681139B2 (en)	1997-08-21
NO954090L (no)	1995-12-13
ES2154674T3 (es)	2001-04-16
CN1058487C (zh)	2000-11-15
KR100364948B1 (ko)	2003-03-29
AU6567694A (en)	1994-11-08
MY131569A (en)	2007-08-30
NZ265272A (en)	1997-07-27
SK281211B6 (sk)	2001-01-18

Publication	Publication Date	Title
OA10355A (en)	2001-10-19	1,5 Benzodiazepine derivatives having cck antagonistic or agonistic activity
US5795887A (en)	1998-08-18	Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
AU679085B2 (en)	1997-06-19	Benzodiazepine analogs
US5739129A (en)	1998-04-14	CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
EP0756602B1 (en)	1999-06-30	Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
OA10236A (en)	1997-10-07	1,5 Benzodiazepine derivatives having cck and/or gastrin antagonistic activity
US5910495A (en)	1999-06-08	Use of 1,5-benzo b!1,4-diazepines to control gastric emptying
US5739162A (en)	1998-04-14	Carbamoylmethylurea derivatives
HK1003943B (en)	2001-06-22	1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity